Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington.

Perfluorooctanesulfonyl fluoride (POSF, C8F17SO2F) related-materials have been used as surfactants, paper and packaging treatments, and surface (e.g., carpet, textile, upholstery) protectants. A metabolite, perfluorooctanesulfonate (PFOS, C8F17SO3-), has been identified in the serum and liver of non-occupationally exposed humans and wildlife. Because of its persistence, an important question was whether elderly humans might have higher PFOS concentrations. From a prospective study designed to examine cognitive function in the Seattle (WA) metropolitan area, blood samples were collected from 238 dementia-free subjects (ages 65-96). High-pressure liquid chromatography-electrospray tandem mass spectrometry determined seven fluorochemicals: PFOS; N-ethyl perfluorooctanesulfonamidoacetate; N-methyl perfluorooctanesulfonamidoacetate; perfluorooctanesulfonamidoacetate; perfluorooctanesulfonamide; perfluorooctanoate; and perfluorohexanesulfonate. Serum PFOS concentrations ranged from less than the lower limit of quantitation (3.4 ppb) to 175.0 ppb (geometric mean 31.0 ppb; 95% CI 28.8-33.4). An estimate of the 95% tolerance limit was 84.1 ppb (upper 95% confidence limit 104.0 ppb). Serum PFOS concentrations were slightly lower among the most elderly. There were no significant differences by sex or years residence in Seattle. The distributions of the other fluorochemicals were approximately an order of magnitude lower. Similar to other reported findings of younger adults, the geometric mean serum PFOS concentration in non-occupational adult populations likely approximates 30-40 ppb with 95% of the population's serum PFOS concentrations below 100 ppb.

[1]  Paul D. Jones,et al.  Accumulation of perfluorooctane sulfonate in marine mammals. , 2001, Environmental science & technology.

[2]  Jeffrey H Mandel,et al.  Epidemiologic Assessment of Worker Serum Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) Concentrations and Medical Surveillance Examinations , 2003, Journal of occupational and environmental medicine.

[3]  Jeffrey H Mandel,et al.  Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. , 2003, Environmental health perspectives.

[4]  J. Mandel,et al.  PLASMA CHOLECYSTOKININ AND HEPATIC ENZYMES, CHOLESTEROL AND LIPOPROTEINS IN AMMONIUM PERFLUOROOCTANOATE PRODUCTION WORKERS , 2000, Drug and chemical toxicology.

[5]  John P Giesy,et al.  Perfluorooctanesulfonate and related fluorinated hydrocarbons in marine mammals, fishes, and birds from coasts of the Baltic and the Mediterranean Seas. , 2002, Environmental science & technology.

[6]  C. Lau,et al.  Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  Wenyue Hu,et al.  Inhibition of gap junctional intercellular communication by perfluorinated compounds in rat liver and dolphin kidney epithelial cell lines in vitro and Sprague-Dawley rats in vivo. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  J Belisle,et al.  Organic fluorine in human serum: natural versus industrial sources. , 1981, Science.

[9]  M. Stanton,et al.  Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  Anton C. Beynen,et al.  New Developments in Biosciences: Their Implications for Laboratory Animal Science , 1988, Springer Netherlands.

[11]  W. Kukull,et al.  The cognitive abilities screening instrument (CASI): data from a cohort of 2524 cognitively intact elderly , 1999, International journal of geriatric psychiatry.

[12]  L. Singer,et al.  Concentrations of ionic, total, and bound fluoride in plasma. , 1979, Clinical chemistry.

[13]  M E Hurtt,et al.  Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. , 1995, Toxicology and applied pharmacology.

[14]  John P Giesy,et al.  Concentrations of perfluorinated acids in livers of birds from Japan and Korea. , 2002, Chemosphere.

[15]  B H Alexander,et al.  Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility , 2003, Occupational and environmental medicine.

[16]  D F Hagen,et al.  Characterization of fluorinated metabolites by a gas chromatographic-helium microwave plasma detector--the biotransformation of 1H, 1H, 2H, 2H-perfluorodecanol to perfluorooctanoate. , 1981, Analytical biochemistry.

[17]  M E Hurtt,et al.  Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  Nathan M. Bass,et al.  Interactions of flurochemicals with rat liver fatty acid-binding protein , 2002 .

[19]  C. Elcombe,et al.  Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. , 2003, Toxicology.

[20]  J. Mandel,et al.  Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. , 1999, Journal of occupational and environmental medicine.

[21]  Scott A Mabury,et al.  Collection of airborne fluorinated organics and analysis by gas chromatography/chemical ionization mass spectrometry. , 2002, Analytical chemistry.

[22]  K. Hansen,et al.  Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. , 2001, Environmental science & technology.

[23]  K. Wallace,et al.  Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis. , 2002, Toxicology letters.

[24]  R. Filler.  Biochemistry Involving Carbon-Fluorine Bonds , 1976 .

[25]  D. Longnecker,et al.  Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643. , 1997, Toxicology and applied pharmacology.

[26]  A. Starkov,et al.  Structural determinants of fluorochemical-induced mitochondrial dysfunction. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[27]  J. Giesy,et al.  Global distribution of perfluorooctane sulfonate in wildlife. , 2001, Environmental science & technology.

[28]  Paul D. Jones,et al.  Perfluorooctane sulfonate in fish-eating water birds including bald eagles and albatrosses. , 2001, Environmental science & technology.

[29]  T. Nevalainen,et al.  A Proposed Species Difference in the Renal Excretion of Perfluoro Octanoic Acid in the Beagle Dog and Rat , 1988 .

[30]  Jeffrey H Mandel,et al.  Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals. , 2003, Environmental science & technology.

[31]  D. Taves,et al.  Evidence that there are Two Forms of Fluoride in Human Serum , 1968, Nature.

[32]  J. S. Eldridge,et al.  Quantitative characterization of trace levels of PFOS and PFOA in the Tennessee River. , 2002, Environmental science & technology.

[33]  S. T. Buckland,et al.  An Introduction to the Bootstrap. , 1994 .

[34]  John P Giesy,et al.  Perfluorooctanesulfonate and related fluorinated hydrocarbons in mink and river otters from the United States. , 2002, Environmental science & technology.

[35]  C. Elcombe,et al.  Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  J. Johnson,et al.  Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]perfluorooctanesulfonate. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.